RT Journal Article
SR Electronic
T1 Forecasting Confirmed Cases and Mortalities of COVID-19 in the US
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.30.20223412
DO 10.1101/2020.10.30.20223412
A1 Jamshidi, Babak
A1 Kakavandi, Mohsen
A1 Zargaran, Shahriar Jamshidi
A1 Talaei-Khoei, Amir
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.10.30.20223412.abstract
AB Background The wide spread of COVID-19 in the US has placed the country as the most infected population worldwide. This paper aims to forecast the number of confirmed cases and mortalities from 12 April to 21 May, 2020. There has been a large body of literature in forecasting epidemic outbreaks such as C algorithms with shortfall of predicting for long periods and autoregressive integrated moving average models with the limited flexibility. However, the US COVID-19 data shows great variety in the relative increments of confirmed cases. This requires a reproductive time series.Method This paper suggests a time series based on the relative increments of confirmed cases. The proposed time series assumes the changes in the time series and provides flexibility. The suggested model was applied on the data observed from 27 February to 11 April 2020 and its objective is forecasting 40 days from 12 April to 21 May 2020.Results It is expected that by May 21, 2020, the accumulative number of confirmed cases of COVID-19 in the US rises to 1,464,729, with 80% confidence interval. Our analysis also shows that by the 21st of May, the cumulative number of mortalities caused by COVID-19 in the US from 18747 cases on 11 April increases to around 73250 cases on 21 May, 2020.Conclusion Our results highlight the value of reproductive strategies in time series modelling of COVID-19. Our model benefits from a reproductive strategy from a time point in which the US COVID-19 data demonstrates a sudden fall.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A https://www.worldometers.info/coronavirus/coronavirus-cases/